TEVA PHARMACEUTICAL-SP ADR
TEVANYSEEarnings Nov 3US Equity
$36.49▲ $0.36 (+1.00%)
Market closed · at close1h—
24h▲ 1.0%
7d▲ 5.1%
14d▲ 5.1%
30d▲ 13.3%
1y▲ 119.8%
🏦Market Cap
$42.50B
Mid Cap
📈Revenue Growth (YoY)
+4.1%
Slowing
📊Gross Margin
52.9%
Healthy
💵FCF Margin
9.0%
Moderate
⚖️P/S Ratio
2.4x
Cheap
Otter Score
68
Fair
🔭
No analyst ratings for TEVA
We don't have Wall Street analyst coverage for this ticker yet. Ratings and price targets appear here as firms publish them.